Industry News External News
Life Sciences & Pharma Articles
Industry News External News
After two years, pharma volumes pick up pace - The Times of India
Industry News External News
Spotlighting the gender gap in pharma research - BusinessLine
Industry News External News
Stock to buy today: Piramal Pharma (₹177.10) - BusinessLine
Google News – Oncology External News
Daiichi aims for $14.6B in oncology sales by 2030 - FirstWord Pharma
Google News – Oncology External News
Prescient Therapeutics (ASX:PTX) Jumps: Could Its Cancer-Therapy Pipeline Become the Next ASX Biotech Catalyst? - Kalkine
Google News – Oncology External News
GSK to file Jemperli for rectal cancer after phase 3 readout - pharmaphorum
Google News – Oncology External News
Clinical Success Is No Longer One Number - Fierce Pharma
Google News – Oncology External News
VERAXA Biotech AG Announces AI Collaboration with Ardigen to Support BiTAC Cancer Therapeutics Pipeline - Quiver Quantitative
Google News – Oncology External News
Merck & Co. stock holds steady as pharma giant leans on diversified drug portfolio - ad-hoc-news.de
Google News – EMA (biotech/pharma) External News
Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis - PR Newswire
Google News – EMA (biotech/pharma) External News
Cogent Biosciences (COGT) Gains 1.92% as Biotech Sector Momentum Builds - Triple EMA - DonanımHaber
Google News – EMA (biotech/pharma) External News
Emalex dopamine blocker stops Tourette syndrome relapse in phase 3 win - Fierce Biotech
Google News – EMA (biotech/pharma) External News
EMA cracks down on JAK inflammatory disease drugs, limiting AbbVie's Rinvoq and more on safety risks - Fierce Pharma
Google News – EMA (biotech/pharma) External News